About Shanghai OPM Biosciences
Shanghai OPM Biosciences is a company based in Pudong (China) founded in 2013.. Shanghai OPM Biosciences has raised $14.42 million across 3 funding rounds from investors including CPE, 3E Bioventures Capital and CoStone Capital. Shanghai OPM Biosciences operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Pudong, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.42 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
CPE
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shanghai OPM Biosciences
Shanghai OPM Biosciences has successfully raised a total of $14.42M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Series B - Shanghai OPM Biosciences | Valuation | CPE | |
| Mar, 2020 | Amount | Series B - Shanghai OPM Biosciences | Valuation | China Life Great Health Fund |
|
| Apr, 2018 | Amount | Seed - Shanghai OPM Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Shanghai OPM Biosciences
Shanghai OPM Biosciences has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include CPE, 3E Bioventures Capital and CoStone Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Acquisitions are targeted by CPE as a private equity firm.
|
Founded Year | Domain | Location | |
|
Tech & Life Science focused early & growth stage VC firm investing in the US & China
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Shanghai OPM Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shanghai OPM Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shanghai Opm Biosciences Comparisons
Competitors of Shanghai OPM Biosciences
Shanghai OPM Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies for the treatment of multiple diseases
|
|
| domain | founded_year | HQ Location |
Antibodies and immunoassay kits are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shanghai Opm Biosciences
Frequently Asked Questions about Shanghai OPM Biosciences
When was Shanghai OPM Biosciences founded?
Shanghai OPM Biosciences was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Where is Shanghai OPM Biosciences located?
Shanghai OPM Biosciences is headquartered in Pudong, China. It is registered at Pudong, Shanghai, China.
Is Shanghai OPM Biosciences a funded company?
Shanghai OPM Biosciences is a funded company, having raised a total of $14.42M across 3 funding rounds to date.
What does Shanghai OPM Biosciences do?
Shanghai OPM Biosciences develops antibody culture media and vaccine culture products. Antibody culture media product such as CHO basic medium, CHO feed medium, and additives vaccine culture products such as BHK21 serum-free medium and MDBK serum-free medium . The company offers technical services such as stable cell line construction, transient transfection expression, personalized media development, cell culture process optimization and antibody analysis.
Who are the top competitors of Shanghai OPM Biosciences?
Shanghai OPM Biosciences's top competitors include Sino Biological, GenScript and Y-Biologics.
Who are Shanghai OPM Biosciences's investors?
Shanghai OPM Biosciences has 5 investors. Key investors include CPE, 3E Bioventures Capital, CoStone Capital, China Life Great Health Fund, and Fortune Capital.